Once-daily insulin detemir is comparable to once-daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: a double-blind, randomized, crossover study.

@article{King2009OncedailyID,
  title={Once-daily insulin detemir is comparable to once-daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: a double-blind, randomized, crossover study.},
  author={Allen King},
  journal={Diabetes, obesity & metabolism},
  year={2009},
  volume={11 1},
  pages={69-71}
}
Once-daily dosing with insulin detemir and insulin glargine were compared in a double-blind, randomised, crossover study in type 2 diabetes subjects previously treated with other antihyperglycaemic medications. Blood glucose was measured through continuous glucose monitoring (CGM). Insulin dose was adjusted daily during the titration phase to achieve target blood glucose values of (70-120 mg/dL) during the basal period, defined as 2400-0600 hours. The last meal of the day started at 1800 h and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 25 extracted citations

Misled by the Morning "Fasting" Plasma Glucose.

Journal of diabetes science and technology • 2015

Number-Based Approach to Insulin Taxonomy

Diabetes therapy : research, treatment and education of diabetes and related disorders • 2015

Similar Papers

Loading similar papers…